Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.riddhisiddhi.co.in | |
Market Cap | 318.63 Cr. | |
Enterprise Value(EV) | 427.66 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -63.42 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-09 |
Industry PE | 70.99 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 2,106.02 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 0.21 | Calculated using Price: 446.90 |
Dividend Yield | 0.34 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.71 Cr. | 7,129,786 Shares |
FaceValue | 10 | |
About Riddhi Siddhi Gluco Biols Ltd. | ||
Riddhi Siddhi Gluco Biols is the one of innovation and adventure, of risks taken and bold decisions made. The seeds of this successful corporate conglomerate were sown in 1990 in the name of Riddhi Siddhi Chemicals Pvt Ltd. In March 1992 the name was changed to Riddhi Siddhi Chemicals Ltd. What followed was an unmatched series of innovations, achievements and accolades. |
1 Day |
|
+1.18% |
1 Week |
|
+2.18% |
1 Month |
|
+16.49% |
3 Month |
|
+7.71% |
6 Month |
|
+30.24% |
1 Year |
|
+20.71% |
2 Year |
|
+23.51% |
5 Year |
|
-8.87% |
10 Year |
|
+108.29% |
8 years | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 3.21 | -3.37 | 0.65 | 4.76 | 1.68 | -4.30 | 3.29 | 2.27 | |
Return on Capital Employed (%) | 5.08 | 1.64 | 1.64 | 6.17 | 3.53 | 0.47 | 4.30 | 3.53 | |
Return on Assets (%) | 2.12 | -2.04 | 0.39 | 3.20 | 1.20 | -3.17 | 2.58 | 1.89 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 1,367 | 1,323 | 1,389 | 1,436 | 1,425 | 1,453 | 1,504 | 1,432 | 1,502 | |
Non Curr. Liab. | 254 | 232 | 169 | 108 | 61 | 96 | 90 | 13 | 12 | |
Curr. Liab. | 347 | 640 | 416 | 357 | 340 | 292 | 156 | 96 | 215 | |
Minority Int. | 107 | 178 | 168 | 165 | 133 | 99 | 87 | 58 | 57 | |
Equity & Liab. | 2,075 | 2,373 | 2,142 | 2,066 | 1,959 | 1,941 | 1,838 | 1,692 | 1,785 | |
Non Curr. Assets | 952 | 1,026 | 1,072 | 1,131 | 976 | 1,341 | 1,298 | 965 | 1,000 | |
Curr. Assets | 1,123 | 1,347 | 1,070 | 935 | 983 | 600 | 539 | 490 | 785 | |
Misc. Exp. not W/O | ||||||||||
Total Assets | 2,075 | 2,373 | 2,142 | 2,066 | 1,959 | 1,941 | 1,838 | 1,692 | 1,785 |
Particulars | 9 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 342 | 508 | 804 | 682 | 576 | 498 | 223 | 173 | 181 | |
Other Income | 134 | 118 | 335 | 70 | 50 | 59 | 62 | 68 | 79 | |
Total Income | 476 | 626 | 1,139 | 752 | 627 | 557 | 285 | 241 | 259 | |
Total Expenditure | -349 | -560 | -1,073 | -605 | -529 | -511 | -200 | -173 | -180 | |
PBIDT | 127 | 66 | 66 | 147 | 98 | 45 | 85 | 68 | 79 | |
Interest | -33 | -52 | -62 | -40 | -31 | -26 | -8 | -8 | -11 | |
Depreciation | -35 | -35 | -34 | -35 | -37 | -37 | -13 | -12 | -17 | |
Taxation | -15 | -25 | 39 | -6 | -6 | -44 | -16 | -15 | -19 | |
Exceptional Items | ||||||||||
PAT | 44 | -45 | 9 | 67 | 24 | -62 | 49 | 33 | 32 | |
Minority Interest | -4 | 3 | 10 | -19 | 9 | 15 | 12 | 29 | 28 | |
Share Associate | ||||||||||
Other Related Items | ||||||||||
Consolidated Net Profit | 40 | -43 | 19 | 49 | 33 | -47 | 14 | -56 | -45 | |
Adjusted EPS | 56 | -60 | 27 | 68 | 46 | -66 | 20 | -78 | -63 |
Particulars | 8 years | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | -284 | -34 | -1 | 116 | 130 | 161 | 1 | |
Cash Fr. Inv. | -67 | 65 | 269 | 163 | 30 | -91 | -71 | 8 | |
Cash Fr. Finan. | -55 | 192 | -263 | -169 | -131 | -108 | -94 | 2 | |
Net Change | -122 | -27 | -28 | -7 | 15 | -69 | -3 | 11 | |
Cash & Cash Eqvt | 2 | 4 | 1 | 1 | 32 | 3 | 0 | 11 |
Sat, 04 Nov 2023
Results- Financial Results For Sep 30 2023 (Standalone And Consolidated) Pursuant to Regulation 30 & 33 of SEBI(LODR) Regulation 2015 we hereby inform you that the Board of Directors of the Company approved and consider standalone and consolidated financial result for the quarter and half year ended on 30.09.2023 along with limited review reports issued by statutory auditor of the Company. |
Sat, 04 Nov 2023
Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Of Riddhi Siddhi Gluco Biols Limited (''Company'') Held On Saturday 04Th November 2023 Pursuant to Regulation 30 & 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 ("Listing Regulations") we hereby inform you that the Board of Directors of the Company has inter alia approved Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended on 30th September 2023 along with Limited Review Reports issued by the Statutory Auditor. |
Sat, 28 Oct 2023
Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended On 30.09.2023. RIDDHI SIDDHI GLUCO BIOLS LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2023 inter alia to consider and approve unaudited financial results (standalone & consolidated) for the quarter and half year ended on 30.09.2023. |
Fri, 01 Dec 2023 |
|
|
|
|
|